Reliance Drugs And Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-05-2024
- Paid Up Capital ₹ 0.99 M
as on 15-05-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2007
- Open Charges ₹ 9.71 M
as on 15-05-2024
About Reliance Drugs And Formulations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2007. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.99 M.
The company currently has active open charges totaling ₹9.71 M.
Giri Singh, Vijay Chawla, and Ameetaraj Singh serve as directors at the Company.
- CIN/LLPIN
U24231CH1989PTC009769
- Company No.
009769
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 1989
- Date of AGM
30 Sep 2007
- Date of Balance Sheet
31 Mar 2007
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- LocationUt, Chandigarh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Reliance Drugs And Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Giri Singh  | Director | 18-Apr-2008 | Current |
| Vijay Chawla | Director | 12-Oct-1989 | Current |
| Ameetaraj Singh | Director | 06-Jan-2009 | Current |
Financial Performance and Corporate Structure Insights of Reliance Drugs And Formulations.
Enhance accessibility to Reliance Drugs And Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Reliance Drugs And Formulations?
Unlock access to Reliance Drugs And Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Reliance Bulk Drugs And Formulations LimitedActive 38 years 9 monthsVijay Chawla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 10 Nov 2008 | ₹1.00 M | Open |
The Haryana Financial Corporation Creation Date: 05 Feb 1997 | ₹4.13 M | Open |
Punjab National Bank Creation Date: 24 Jun 1993 | ₹0.15 M | Open |
How Many Employees Work at Reliance Drugs And Formulations?
Unlock and access historical data on people associated with Reliance Drugs And Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reliance Drugs And Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reliance Drugs And Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
